1. Medtech Insight
  2. >>Device Area
  3. >>Surgery

Market Intel: Robotic Surgery Holds Great Promise, But Is Not Quite There Yet

 
• By Marion Webb

In this final part of a three-part series on the “Future of Surgery” we highlight perspectives of a highly skilled orthopedic robotic surgeon on where we are today in robotic surgery and where we are going, introduce innovative surgical robotics companies, and discuss medtechs’ rising role in robotic surgery.

Roboticsurgery

The future of robotic surgery is bright and will be driven by smaller, more usable, intelligent robotic systems that can perform a wider range of procedures. Advances in artificial intelligence, machine learning and sensor technologies are also expected to drive the autonomy of robotic surgery systems. Proponents of surgical robots tout benefits such as less variability in a procedure, shorter recovery time, more precision and better outcomes.

But in many ways robotic-assisted surgeries still rely on highly skilled surgeons.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Robotic Surgery

More from Surgery

J&J MedTech Launches KINCISE 2 Surgical Automated System In US

 
• By Natasha Barrow

The KINCISE 2 Surgical Automated System aims to “reduce the physical burden on surgeons compared to manual impaction in primary and revision hip and revision knee replacement procedures,” said J&J MedTech.

Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System

 
• By Marion Webb

Abbott received the US FDA nod for its Tendyne system, offering a minimally invasive alternative to replace the valves of patients with severe mitral valve disease who are at risk for open-heart surgery.

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 
• By Brian Bossetta

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.